The MAO‐B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti‐Androgen and Cytostatic Agents

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Anita Steib, Krisztina Pohóczky, Norbert Tóth, Viktória Kormos, József Kun, Tamás Kálai, László Mangel, Péter Mátyus, Zsuzsanna Helyes
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pharmacology Research & Perspectives
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items